Project Grant HT94252510929
- The University of California, San Diego (UCSD) was awarded a $789,987.00 Project Grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, awarded on August 1, 2023 with a completion date of July 31, 2026, will support research on CTL-tolerant melanoma persister cells. The research aims to transform health care for Service Members and the American public through innovative and impactful research, and to investigate...
- The University of California, San Diego (UCSD) was awarded a $592,500.00 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to develop a "Mutant DNA-Activated Killing System for Precision Breast Cancer Therapy." The award, which spans from February 1, 2025 to January 31, 2028, aims to support advanced biomedical research to transform healthcare for military service members, veterans, and the broader public. UCSD, a...
- This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,197,813.00 to the University of California, San Diego (UCSD) to conduct research on the mechanism and modeling of the human PD1 protein in melanoma. The award period runs from August 15, 2025 to August 14, 2028. UCSD, a leading academic medical research institution, will leverage its expertise in neuroscience, biomedical engineering, and healthcare to...
- The University of California, San Diego (UCSD) was awarded a $1,218,012 Project Grant from the Defense Health Agency on September 30, 2023 under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "GERMLINE INFLUENCE ON PROSTATE CANCER METASTASIS AND TREATMENT RESPONSE." The research aims to transform health care for Service Members and the American public by investigating medical solutions for the battlefield through innovative and impactful...
- The University of California, San Diego (UC San Diego) was awarded a $592,500 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on February 1, 2025, supports the development of a "Mutant DNA-Activated Killing System for Precision Breast Cancer Therapy". The research aims to transform healthcare for military service members, veterans, and the broader public by advancing innovative biomedical...
- The University of California, San Diego (UCSD) was awarded a $1,184,999 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will support UCSD's project "QUANTITATIVE ADVANCED DIFFUSION MRI FOR RELIABLE DETECTION AND ENHANCED TREATMENT OF HIGH-GRADE PROSTATE CANCER" from July 1, 2023 to June 30, 2027. Through this funding, UCSD will conduct research to advance the detection and treatment of high-grade prostate...
- The University of California, San Diego (UCSD) was awarded a $790,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will support UCSD research to mitigate traumatic brain injuries and neurological implications via the immunometabolite itaconate from June 1, 2023 through May 31, 2026. The Military Medical Research and Development program aims to transform military and public health care through...
- The University of California, San Diego (UCSD) was awarded a $551,207.00 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to research a new therapeutic target to prevent pancreatic cancer metastasis. The 3-year grant period runs from July 1, 2023 to June 30, 2026. The project aims to investigate medical solutions for the battlefield by transforming health care through innovative and impactful research in areas like cancer...
- The University of California, San Diego (UCSD), doing business as UC San Diego Health, was awarded a $1,580,000 Project Grant from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420). The grant, awarded on March 1, 2025, will support a research project titled "Multiomic Approaches for Noninvasive Prediction of Inflammatory Bowel Disease Exacerbations." The project aims to develop innovative biomedical solutions to address critical health...
- The University of California, San Diego (UCSD) was awarded a $1,995,027.00 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "THERAPY FOR C9ALS USING ENGINEERED RNA-TARGETING ZINC FINGER PROTEINS". The award period runs from June 1, 2025 to May 31, 2028. The project aims to advance biomedical research that can transform healthcare for military service members, veterans, and the general public....
The University of California, San Diego (UCSD) was awarded a $1,197,884.00 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). The 3-year grant, awarded on Aug 15, 2025, supports research to investigate the mechanism and develop models of the human PD1 protein in the context of melanoma. As a leading academic institution, UCSD will leverage its expertise in medical research and education to conduct this advanced biomedical research aimed at transforming healthcare for military service members and the broader public. The Project Grant demonstrates the DHA's commitment to funding innovative, impactful research that has the potential to address critical health challenges relevant to military personnel.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $1.2m | 8/5/25 |